Search for content, post, videos

Alligator and Orion initiate second immuno-oncology program

Søren Bregenholt and Outi Vaarala
Alligator Bioscience has announced an expansion to its research collaboration and license agreement with Orion Corporation, to discover and develop together new bispecific antibody cancer therapeutics. The collaboration has been expanded to add the development of a second bispecific antibody usin
Already a subscriber Login

You have read all your free articles, to continue reading subscribe to read the rest of this content.